Abstract

Acute lung injury (ALI) is characterized by inflammation of the lung tissue and oxidative injury caused by excessive accumulation of reactive oxygen species. Studies have suggested that anti-inflammatory or antioxidant agents could be used for the treatment of ALI with a good outcome. Therefore, our study aimed to test whether the mycelium extract of Sanghuangporus sanghuang (SS-1), believed to exhibit antioxidant and anti-inflammatory properties, could be used against the excessive inflammatory response associated with lipopolysaccharides (LPS)-induced ALI in mice and to investigate its possible mechanism of action. The experimental results showed that the administration of SS-1 could inhibit LPS-induced inflammation. SS-1 could reduce the number of inflammatory cells, inhibit myeloperoxidase (MPO) activity, regulate the TLR4/PI3K/Akt/mTOR pathway and the signal transduction of NF-κB and MAPK pathways in the lung tissue, and inhibit high mobility group box-1 protein 1 (HNGB1) activity in BALF. In addition, SS-1 could affect the synthesis of antioxidant enzymes Heme oxygenase 1 (HO-1) and Thioredoxin-1 (Trx-1) in the lung tissue and regulate signal transduction in the KRAB-associated protein-1 (KAP1)/nuclear factor erythroid-2-related factor Nrf2/Kelch Like ECH associated Protein 1 (Keap1) pathway. Histological results showed that administration of SS-1 prior to induction could inhibit the large-scale LPS-induced neutrophil infiltration of the lung tissue. Therefore, based on all experimental results, we propose that SS-1 exhibits a protective effect against LPS-induced ALI in mice. The mycelium of S. sanghuang can potentially be used for the treatment or prevention of inflammation-related diseases.

Highlights

  • Acute Lung Injury (ALI) is a condition where lung tissue is injured by excessive nonspecific acute inflammatory response in the lungs [1]

  • Excessive concentrations of NO and pro-inflammatory cytokines in the body play a key role in the pathogenesis of LPS-induced ALI

  • Antibodies against iNOS, COX-2, p-ERK1/2, p-JNK, JNK, Trx-1, Keap-1, KRAB-associated protein-1 (KAP1), GPX1, CAT, superoxide dismutase (SOD)-1, TLR4, AKT and HMGB1 were purchased from Gene Tex (San Antonio, TX, USA)

Read more

Summary

Introduction

Acute Lung Injury (ALI) is a condition where lung tissue is injured by excessive nonspecific acute inflammatory response in the lungs [1]. The inhibition of mTOR reduces LPS-induced synthesis of pro-inflammatory cytokines and NF-κB phosphorylation, indicating that the PI3K/Akt/mTOR/IKK signal transduction pathways greatly affect the activation of NF-κB [8,9,10,11]. Effects of SS-1 on LPS-Induced Antioxidative Enzymes and HO-1, Trx-1, KAP1/Nrf Protein Expressions in Macrophage. Effect of SS-1 on BALF Cytokine Levels and iNOS, COX-2 Protein Expressions in LPS-Induced ALI Mice. Excessive concentrations of NO and pro-inflammatory cytokines in the body play a key role in the pathogenesis of LPS-induced ALI. The administration of SS-1 prior to induction increased the cytoplasmic expression levels of NF-κB p65 and IκBα, while reducing

Effects of SS-1 on NF-κB and MAPK Activation in LPS Induced ALI Mice
2.10. HPLC Profifile of SS-1
Source of Material
Sample Extraction
Cell Culture
Cytotoxicity and NO Production
Animals
Model of LPS Induced ALI
4.12. Protein Extraction and Western Blot Analysis
4.13. Fingerprint Analysis by HPLC
4.14. Statistical Analysis
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call